Post-Operative Pain Management Market Overview

One of the most common and the most adverse outcomes post operation is excruciating pain. This pain causes prolonged stays at the hospital, physical and mental distress, and readmission of the patient into the hospital or medical center. This sparks the need for post-operative pain management that helps minimize the pain the patient experiences after surgery. It is highly crucial and is a much more preferred option than single analgesics as it is not the best solution when it comes to providing effective pain relief for moderate to severe pain. Additionally, the latter causes side effects like bleeding, vomiting, sedation, or nausea. This branch of pain management not only helps reduce the pain intensity, but it also helps improve the results of the operation and increases their level of comfort.

The post-operative pain management market is anticipated to reach USD 4,550 Million by 2030 at 6.80% CAGR during the forecast period 2022-2030, reveals the latest Market Research Future (MRFR) report. Post-operative pain is unpleasant and annoying, which, if not treated correctly and on time, can result in chronic pain, which may last for months. Post-operative pain is a common adverse outcome owing to physical distress, prolonged hospital stays, and the growing incidence of readmissions of patients after surgery. Post-operative pain management helps in minimizing patient discomfort, facilitating early mobilization, functional recovery along with preventing acute pain turning into chronic pain. Besides, it also helps to lessen the possibility of pulmonary, cardiac, and neuropathic pain complications, low cost of care, and cut down the risk of thrombosis. 

It is a highly critical part of the patient treatment process as it ensures comfort, reduces the potential possibility of pulmonary, cardiac, and neuropathic pain complications, initiates mobilization, curbs down the risk of thrombosis, and the expenses of related to patient care. An in-depth and extensive study of the global post-operative pain management market reveals a steady growth potential of 5.4% CAGR during the forecast period of 2017 to 2023.

The pain arising post-surgery due to tissue injury and muscle spasm in a patient requires special attention because such kind of pain is a symptom that indicates a patient’s undiagnosed discomforts after surgery. This acute post-operative pain often tends to transform into chronic pain if not managed properly. Dovepress, a pain research journal, states that around 80% patients in the United States receive the desirable postoperative pain treatment. Enhanced post-operative pain management contributes to a patient’s quick rehabilitation and hence, sooner hospital discharge thereby, reducing medical expenses of the patient. This increases patient’s satisfaction which is expected to contribute largely to the global Post-Operative Pain Management Market expansion. Increasing prevalence of diseases that require surgical attention, like laparoscopic cholecystectomy and rise in the number of patients afflicted with diseases like cancer are other factors impelling the market growth. The rise in necessity of providing effective pain management with minimum side effect is creating immense opportunity for the market key players to invest in research and development activities which are anticipated to positively impact the postoperative pain management market expansion.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1246

Post-Operative Pain Management Market Segmentation

The global post-operative pain management market segmentation is classified in terms of pain, product, target area, and application.

By pain type, the market includes moderate pain, acute pain, and severe pain.

By product, the market segments into COX-2 inhibitors, antiepileptic drugs, non-steroidal anti-inflammatory drugs (NSAIDs), opioids and other analgesics.

By target area, the market includes legs, arms, hands, back, and others.

By application, the market includes arthritic pain, musculoskeletal pain, cancer pain, migraine pain, neuropathic pain, and others.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/post-operative-pain-management-market-1246

Post-Operative Pain Management Market Regional Analysis

The geographical segmentation of the global post-operative pain management market includes the Americas, Asia Pacific, the Middle East & Africa, and Europe.

Among all these mentioned regions, Americas accounts for the largest market with over 50% of the global market share to its name.                             The dominance of the region is primarily due to the huge patient pool undergoing surgical operations and the availability of a well-established healthcare infrastructure herein.  Also, the rising burden in relation to chronic diseases has also contributed to the market’s growth of the region.

Europe has the second-largest market for post-operative pain management. This is due to the rising number of research and development activities that are undergoing herein for the identification and introduction of new drugs with fewer side-effects.

The Asia-Pacific region is estimated to be the fastest market player due to the prevalence of chronic diseases which need surgical treatments, development in the healthcare industry, and the fast-paced expansion of the geriatric population. Finally, the Middle Eastern & African region is expected to experience a steady growth period due to poor primary level healthcare services in the underdeveloped regions and lack of awareness concerning the market.

Competitive Analysis                                       

Eli Lilly (U.S), Pfizer (U.S), Purdue Pharma (U.S), Teva Pharmaceutical Industries Ltd. (Israel), Valeant Pharmaceuticals International Inc. (Canada), Forest Laboratories Inc. (U.S), Baxter International Inc. (US), Endo Pharmaceuticals Plc. (U.S), Johnson & Johnson (U.S), F. Hoffmann-La Roche Ltd. (Switzerland), and GlaxoSmithKline Plc. (UK) are some of the most prominent players in the global post-operative pain management market.

Industry Update

April 2019: American Society of Regional Anesthesia and Pain Medicine (ASRA) reported that regional anaesthesia with lidocaine infusion reduces postoperative pain for patients undergoing primary hip arthroplasty, according to research from Stanford University in Stanford, CA.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com